Terms: = Lymphoma AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Clinical Outcome
12 results:
1. Influence of Immunogenetic Biomarkers in the clinical outcome of HTLV-1 Infected Persons.
Vallinoto ACR; Cayres-Vallinoto I; Freitas Queiroz MA; Ishak MOG; Ishak R
Viruses; 2019 Oct; 11(11):. PubMed ID: 31652745
[TBL] [Abstract] [Full Text] [Related]
2. Resistance to apoptosis should not be taken as a hallmark of cancer.
Wang RA; Li ZS; Yan QG; Bian XW; Ding YQ; Du X; Sun BC; Sun YT; Zhang XH
Chin J Cancer; 2014 Feb; 33(2):47-50. PubMed ID: 24417874
[TBL] [Abstract] [Full Text] [Related]
3. Cellular (FLICE) like inhibitory protein (cFLIP) expression in diffuse large B-cell lymphoma identifies a poor prognostic subset, but fails to predict the molecular subtype.
Harris J; Ibrahim H; Amen F; Karadimitris A; Naresh KN; Macdonald DH
Hematol Oncol; 2012 Mar; 30(1):8-12. PubMed ID: 21638304
[TBL] [Abstract] [Full Text] [Related]
4. clinical and prognostic significance of apoptotic profile in patients with newly diagnosed nodal diffuse large B-cell lymphoma (DLBCL).
Markovic O; Marisavljevic D; Cemerikic V; Perunicic M; Savic S; Filipovic B; Mihaljevic B
Eur J Haematol; 2011 Mar; 86(3):246-55. PubMed ID: 21198858
[TBL] [Abstract] [Full Text] [Related]
5. Serum soluble fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP.
Hara T; Tsurumi H; Goto N; Kanemura N; Yoshikawa T; Kasahara S; Yamada T; Sawada M; Goto H; Fukuno K; Kitagawa J; Yasuda I; Katsumura N; Takemura M; Takahashi T; Takami T; Moriwaki H
J Cancer Res Clin Oncol; 2009 Oct; 135(10):1421-8. PubMed ID: 19381687
[TBL] [Abstract] [Full Text] [Related]
6. fas 670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia.
Farre L; Bittencourt AL; Silva-Santos G; Almeida A; Silva AC; Decanine D; Soares GM; Alcantara LC; Van Dooren S; Galvão-Castro B; Vandamme AM; Van Weyenbergh J
J Leukoc Biol; 2008 Jan; 83(1):220-2. PubMed ID: 17962369
[TBL] [Abstract] [Full Text] [Related]
7. The anti-asparagines antibodies correlate with L-asparagines activity and may affect clinical outcome of childhood acute lymphoblastic leukemia.
Zalewska-Szewczyk B; Andrzejewski W; Młynarski W; Jedrychowska-Dańska K; Witas H; Bodalski J
Leuk Lymphoma; 2007 May; 48(5):931-6. PubMed ID: 17487737
[TBL] [Abstract] [Full Text] [Related]
8. fas and fas ligand expression on germinal center type-diffuse large B-cell lymphoma is associated with the clinical outcome.
Kojima Y; Tsurumi H; Goto N; Shimizu M; Kasahara S; Yamada T; Kanemura N; Hara T; Sawada M; Saio M; Yamada T; Takahashi T; Tomita E; Takami T; Moriwaki H
Eur J Haematol; 2006 Jun; 76(6):465-72. PubMed ID: 16494623
[TBL] [Abstract] [Full Text] [Related]
9. cFLIP expression correlates with tumour progression and patient outcome in non-Hodgkin lymphomas of low grade of malignancy.
Valente G; Manfroi F; Peracchio C; Nicotra G; Castino R; Nicosia G; Kerim S; Isidoro C
Br J Haematol; 2006 Mar; 132(5):560-70. PubMed ID: 16445828
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic significance of apoptosis-related cd95 antigen expression in patients with non-Hodgkin's lymphoma.
Zodelava M; Datikashvili-David I
Georgian Med News; 2005 Mar; (120):37-9. PubMed ID: 15855696
[TBL] [Abstract] [Full Text] [Related]
11. c-Flip protein expression in Burkitt's lymphomas is associated with a poor clinical outcome.
Valnet-Rabier MB; Challier B; Thiebault S; Angonin R; Margueritte G; Mougin C; Kantelip B; Deconinck E; Cahn JY; Fest T
Br J Haematol; 2005 Mar; 128(6):767-73. PubMed ID: 15755279
[TBL] [Abstract] [Full Text] [Related]
12. Altered apoptosis pathways in mantle cell lymphoma.
Rummel MJ; de Vos S; Hoelzer D; Koeffler HP; Hofmann WK
Leuk Lymphoma; 2004 Jan; 45(1):49-54. PubMed ID: 15061196
[TBL] [Abstract] [Full Text] [Related]